⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INTS News
Intensity Therapeutics, Inc. Common stock
Form 8-K
sec.gov
INTS
Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update
prnewswire.com
INTS
Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US
prnewswire.com
INTS
Form 8-K
sec.gov
INTS
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
prnewswire.com
INTS
Form 8-K
sec.gov
INTS
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
prnewswire.com
INTS
Form 8-K
sec.gov
INTS
Intensity Therapeutics Announces Reverse Stock Split
prnewswire.com
INTS
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities
prnewswire.com
INTS